These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 13528781)

  • 21. [Changes in the cerebrospinal fluid pH in nervous system diseases].
    Zhang CG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Sep; 15(3):167-9. PubMed ID: 7151578
    [No Abstract]   [Full Text] [Related]  

  • 22. [Transaminase activity of cerebrospinal fluid in various diseases of the central nervous system].
    YANG YM; CHENG ST; CHEN JS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1961; 2():132-40. PubMed ID: 14008976
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum and cerebrospinal-fluid transaminase concentrations in various neurologic disorders.
    MYERSON RM; HURWITZ JK; SALL T
    N Engl J Med; 1957 Aug; 257(6):273-6. PubMed ID: 13452089
    [No Abstract]   [Full Text] [Related]  

  • 24. Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders.
    Maxeiner HG; Rojewski MT; Schmitt A; Tumani H; Bechter K; Schmitt M
    Brain Behav Immun; 2009 Jan; 23(1):134-42. PubMed ID: 18771722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Transaminase activity of cerebrospinal fluid].
    PARIANTE F
    Boll Soc Ital Biol Sper; 1958 Feb; 34(4):129-31. PubMed ID: 13536023
    [No Abstract]   [Full Text] [Related]  

  • 26. [The glutamic-oxalacetic transaminase activity of the cerebrospinal fluid of newborn infants in normal and pathological conditions].
    IANNIRUBERTO A
    Arch Ostet Ginecol; 1961; 66():363-71. PubMed ID: 13717275
    [No Abstract]   [Full Text] [Related]  

  • 27. [CSF transaminases in schizophrenia].
    RABASSINI A; CHIRILLO R
    Acta Vitaminol; 1957 Oct; 11(5):197-200. PubMed ID: 13497855
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of spinal fluid transaminase determination in the differential diagnosis of low back pain.
    STEVENS JD; HUMOLLER FL; MAJKA FA
    Bull Los Angel Neuro Soc; 1959 Dec; 24():220-3. PubMed ID: 13834538
    [No Abstract]   [Full Text] [Related]  

  • 29. [Glutamic-oxalacetic and glutamic-pyruvic transaminases in the cerebrospinal fluid].
    CIOCIA D; NODARI G
    Riforma Med; 1958 Sep; 72(36):1014-8. PubMed ID: 13592013
    [No Abstract]   [Full Text] [Related]  

  • 30. [Limitations of paper electrophoretic determination of blood & CSF proteins in neurological & psychiatric diseases].
    SARTESCHI P; FABIANI P
    Rass Studi Psichiatr; 1956; 45(6):1193-228. PubMed ID: 13420573
    [No Abstract]   [Full Text] [Related]  

  • 31. Transaminase, amounts in cerebrospinal fluid.
    ARST HE
    J Kans Med Soc; 1959 May; 60(6):214-9. PubMed ID: 13654874
    [No Abstract]   [Full Text] [Related]  

  • 32. [Glutamic-oxalacetic and glutamic pyruvic transaminases in diseases of the nervous system].
    MANAI G; MANDELLI F; SAGINARIO M
    Riv Sper Freniatr Med Leg Alien Ment; 1958 Sep; 82(3):726-37. PubMed ID: 13602621
    [No Abstract]   [Full Text] [Related]  

  • 33. High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid.
    Arneth B; Birklein F
    Acta Neurol Scand; 2009 Jan; 119(1):39-44. PubMed ID: 18573131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Research on vasomotor reactivity in nervous and mental diseases].
    ANDREANI G; CASTELLETTI V
    G Psichiatr Neuropatol; 1951; 79(3):361-74. PubMed ID: 14906832
    [No Abstract]   [Full Text] [Related]  

  • 35. [CSF levels and diagnostic utility of cerebrospinal fluid beta2-microglobulin].
    Caudie C; Bancel J; Dupont M; Matanza D; Poitevin F; Honnorat J
    Ann Biol Clin (Paris); 2005; 63(6):631-7. PubMed ID: 16330382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroscience. The dark side of glia.
    Miller G
    Science; 2005 May; 308(5723):778-81. PubMed ID: 15879185
    [No Abstract]   [Full Text] [Related]  

  • 37. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
    Hirohata S; Arinuma Y; Takayama M; Yoshio T
    Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of isohemo-agglutination in relation to the nervous system].
    ANDREANI G
    G Psichiatr Neuropatol; 1954; 82(3):677-743. PubMed ID: 14353318
    [No Abstract]   [Full Text] [Related]  

  • 39. Cognitive and neuropsychological disorders in neuroimmunological diseases.
    Zettl UK; Mix E
    J Neurol; 2007 May; 254 Suppl 2():II1. PubMed ID: 17503115
    [No Abstract]   [Full Text] [Related]  

  • 40. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.